NCT03830957
Unknown
Not Applicable
Randomized Clinical Trial of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
Rajaie Cardiovascular Medical and Research Center1 site in 1 country200 target enrollmentNovember 26, 2018
Overview
- Phase
- Not Applicable
- Intervention
- Ivabradine
- Conditions
- Heart Failure
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Heart rate
- Last Updated
- 7 years ago
Overview
Brief Summary
The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Sinus rhythm
- •Heart rate \>60/min
Exclusion Criteria
- •Atrial fibrillation
- •Any contraindication for beta-blocker use
Arms & Interventions
Ivabradine
Intervention: Ivabradine
metoprolol
Intervention: Metoprolol
Outcomes
Primary Outcomes
Heart rate
Time Frame: 30 minutes before and after coronary CT angiography
Changing heart rate during imaging study
Secondary Outcomes
- Dyspnea(30 minutes before and after coronary CT angiography and 6 months later)
- Blood pressure, systolic and diastolic(30 minutes before and after coronary CT angiography and 6 months later)
- Hypotension(30 minutes before and after coronary CT angiography)
- Sleep quality(Before CT angiography and 6 months later)
- Functional calss(30 minutes before and after coronary CT angiography and 6 months later)
- Appetite(Before CT angiography and 6 months later)
- Prolonged bradycardia(30 minutes before and after coronary CT angiography)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary SyndromeAcute Coronary SyndromesNCT00815100Hospital Universitario de Canarias27
Withdrawn
Phase 4
Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular PacingHeart Rate Control in ICD Patients With Heart FailureNCT01868880Policlinico Casilino ASL RMB
Unknown
Phase 4
Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart DiseaseCoronary Artery DiseaseCoronary ArteriosclerosisNCT01768585University Hospital, Saarland50
Unknown
Phase 4
Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on DobutamineHeart FailureCardiogenic ShockTachycardiaNCT03387605Loyola University40
Completed
Phase 3
The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic DysfunctionCoronary DiseaseVentricular Dysfunction, LeftNCT00143507Institut de Recherches Internationales Servier10,917